Key statistics
On Monday, IDEAYA Biosciences Inc (30J:FRA) closed at 27.00, -16.15% below its 52-week high of 32.20, set on Jan 08, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 27.00 |
|---|---|
| High | 27.00 |
| Low | 27.00 |
| Bid | 28.20 |
| Offer | 28.40 |
| Previous close | 26.80 |
| Average volume | 38.00 |
|---|---|
| Shares outstanding | 87.81m |
| Free float | 87.00m |
| P/E (TTM) | -- |
| Market cap | 2.83bn USD |
| EPS (TTM) | -1.30 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:39 GMT.
More ▼
Press releases
- Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
- Biocytogen Announces Clinical Milestone with First Patient Dosed in Phase 1 Trial of IDEAYA’s First-in-Class B7H3/PTK7 Bispecific TOP1 ADC IDE034
- IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
- IDE034, a Bispecific ADC Licensed by Biocytogen to IDEAYA, Receives FDA IND Clearance
